Oragenics, Inc. (OGEN)

Last Closing Price: 0.12 (2025-05-30)

Return on Equity (Quarterly)

Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity

Oragenics, Inc. (OGEN) had Return on Equity of -1610.07% for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
--
$-2.22M
--
--
$2.03M
$-2.03M
$-0.19M
$-2.22M
$-2.22M
$-2.22M
$-2.22M
$-2.22M
$-2.22M
$-2.03M
$-1.83M
18.22M
18.22M
$-0.12
$-0.12
Balance Sheet Financials
$3.87M
--
--
$3.87M
$3.73M
--
--
$3.73M
$0.14M
$0.14M
$0.14M
21.48M
Cash Flow Statement Financials
$-2.11M
--
$4.67M
$0.86M
$3.42M
$2.56M
$-0.07M
--
--
Fundamental Metrics & Ratios
1.04
--
--
--
18.55
--
--
--
--
--
--
$-2.11M
--
--
--
--
--
--
--
Return on Equity
-1610.07%
-1610.15%
-57.30%
-1610.16%
$0.01
$-0.12
$-0.12